THRN — Thorne HealthTech Income Statement
0.000.00%
Last trade - 00:00
HealthcareAdventurousMid Cap
- $550.63m
- $563.26m
- $228.73m
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 103 | 138 | 184 | 229 |
Cost of Revenue | ||||
Gross Profit | 44.7 | 64.8 | 96.4 | 115 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 116 | 137 | 175 | 223 |
Operating Profit | -13.9 | 1.01 | 9.59 | 5.48 |
Total Net Non Operating Interest Income / Expense | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -16.6 | -2.27 | 10.9 | 7.8 |
Provision for Income Taxes | ||||
Net Income After Taxes | -16.6 | -2.44 | 10.5 | 15.1 |
Minority Interest | ||||
Equity in Affiliates | ||||
Net Income Before Extraordinary Items | ||||
Net Income | -16.7 | -3.36 | 7.25 | 15.7 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -21.5 | -3.36 | 3.75 | 15.7 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -211 | -32.8 | 0.104 | 0.303 |
Dividends per Share |